BRISANDER; Magnus
Patent Applications and Registrations
Patent applications and USPTO patent grants for BRISANDER; Magnus.The latest application filed is for "pharmaceutical compositions".
- BRISANDER; Magnus - Ekero SE
| Patent | Date |
|---|---|
| Pharmaceutical Compositions App 20220296575 - BRISANDER; Magnus ; et al. | 2022-09-22 |
| Pharmaceutical compositions Grant 11,426,391 - Brisander , et al. August 30, 2 | 2022-08-30 |
| Fast Dissolving Pharmaceutical Compositions App 20220233532 - BRISANDER; Magnus ; et al. | 2022-07-28 |
| Pharmaceutical compositions Grant 11,376,243 - Brisander , et al. July 5, 2 | 2022-07-05 |
| Pharmaceutical Compositions App 20220168285 - BRISANDER; Magnus ; et al. | 2022-06-02 |
| Pharmaceutical Compositions App 20220160687 - BRISANDER; Magnus ; et al. | 2022-05-26 |
| Pharmaceutical Compositions App 20220117947 - BRISANDER; Magnus ; et al. | 2022-04-21 |
| Pharmaceutical compositions Grant 11,241,419 - Brisander , et al. February 8, 2 | 2022-02-08 |
| Injectable Suspensions App 20210100736 - Brisander; Magnus ; et al. | 2021-04-08 |
| Pharmaceutical Compositions App 20210093616 - BRISANDER; Magnus ; et al. | 2021-04-01 |
| Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereof Grant 10,933,014 - Brisander , et al. March 2, 2 | 2021-03-02 |
| Pharmaceutical compositions Grant 10,772,877 - Brisander , et al. September 15, 2 | 2020-09-15 |
| Pharmaceutical Compositions App 20200253941 - Kind Code | 2020-08-13 |
| Pharmaceutical compositions Grant 10,561,645 - Brisander , et al. Feb | 2020-02-18 |
| Pharmaceutical compositions Grant 10,561,644 - Brisander , et al. Feb | 2020-02-18 |
| Pharmaceutical compositions Grant 10,561,643 - Brisander , et al. Feb | 2020-02-18 |
| Pharmaceutical compositions Grant 10,555,937 - Brisander , et al. Feb | 2020-02-11 |
| Injectable Suspensions App 20190350838 - Brisander; Magnus ; et al. | 2019-11-21 |
| Pharmaceutical Compositions App 20190282553 - BRISANDER; Magnus ; et al. | 2019-09-19 |
| Pharmaceutical Compositions App 20190275019 - BRISANDER; Magnus ; et al. | 2019-09-12 |
| Pharmaceutical Compositions App 20190275018 - BRISANDER; Magnus ; et al. | 2019-09-12 |
| Pharmaceutical Compositions App 20190255029 - BRISANDER; Magnus ; et al. | 2019-08-22 |
| Pharmaceutical compositions Grant 10,314,830 - Brisander , et al. | 2019-06-11 |
| Pharmaceutical compositions Grant 10,314,829 - Brisander , et al. | 2019-06-11 |
| Pharmaceutical Compositions App 20190076413 - BRISANDER; Magnus ; et al. | 2019-03-14 |
| Pharmaceutical Compositions App 20190060294 - Brisander; Magnus ; et al. | 2019-02-28 |
| Pharmaceutical compositions Grant 10,143,683 - Brisander , et al. De | 2018-12-04 |
| Pharmaceutical Compositions App 20180042906 - BRISANDER; Magnus ; et al. | 2018-02-15 |
| Pharmaceutical compositions Grant 9,833,443 - Brisander , et al. December 5, 2 | 2017-12-05 |
| Pharmaceutical compositions Grant 9,833,442 - Brisander , et al. December 5, 2 | 2017-12-05 |
| Pharmaceutical compositions Grant 9,827,230 - Brisander , et al. November 28, 2 | 2017-11-28 |
| Pharmaceutical Compositions App 20170143715 - BRISANDER; Magnus ; et al. | 2017-05-25 |
| Pharmaceutical Compositions App 20170143683 - BRISANDER; Magnus ; et al. | 2017-05-25 |
| Pharmaceutical Compositions App 20160361313 - BRISANDER; Magnus ; et al. | 2016-12-15 |
| Pharmaceutical composition comprising stable, amorphous, hybrid nanoparticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix forming component Grant 9,456,992 - Brisander , et al. October 4, 2 | 2016-10-04 |
| Novel Methods App 20160250153 - BRISANDER; Magnus ; et al. | 2016-09-01 |
| Picropodophyllin polymorph C and its use in cancer therapy Grant 9,314,525 - Bisrat , et al. April 19, 2 | 2016-04-19 |
| Tiotropium Preparations App 20150231120 - Jesson; Gerald ; et al. | 2015-08-20 |
| Novel Methods App 20140378454 - Brisander; Magnus ; et al. | 2014-12-25 |
| Pharmaceutical Composition Comprising Stable, Amorphous, Hybrid Nanoparticles Of At Least One Protein Kinase Inhibitor And At Least One Polymeric Stabilizing And Matrix-forming Component App 20140356443 - Brisander; Magnus ; et al. | 2014-12-04 |
| Picropodophyllin Monohydrate or Polymorph A in Cancer Therapy App 20130331445 - Bisrat; Mikael ; et al. | 2013-12-12 |
| Picropodophyllin Polymorphs B or C for Use in Cancer Therapy App 20130317099 - Bisrat; Mikael ; et al. | 2013-11-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 